Influence of serum levels of luteinizing hormone during controlled ovarian hyperstimulation on the results of IVF cycle;Vplyv sérových hladín luteinizačného hormónu počas kontrolovanej ovariálnej hyperstimulá cie na výsledky cyklu IVF

Ceska Gynekologie

Volumn 70, Issue 4, 2005, Pages 247-253

  Toporcerová, Silvia ^a,c   Hredzak R ^a   Ostro A ^a   Zdilova V ^a   Adam, J ^a   Potocekova D ^b  

^a Med Faculty of Safarik University   (Slovakia)

^b P J AFÁRIK UNIVERSITY   (Slovakia)

^c LF   (Slovakia)

Author keywords

Controlled ovarian stimulation; IVF; Luteinizing hormone

Indexed keywords

GONADORELIN AGONIST; LUTEINIZING HORMONE; TRIPTORELIN;

ADULT; ARTICLE; FEMALE; FERTILIZATION IN VITRO; HUMAN; INFERTILITY; INFERTILITY THERAPY; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; OVULATION INDUCTION; PREGNANCY RATE; PROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 23244442832     PISSN: 12107832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Balasch, J., Vidal, E., Pañarrubia, J., et al. Suppression of LH during ovarian stimulation: analysis threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH. Hum. Reprod., 2001, 16, p. 1636-1643.
2. Battaglia, C., Salvatori, M., Regnani, G., et al. Successful induction of ovulation using highly purified follicle-stimulating hormone in a woman with Kallmann's syndrome. Fertil Steril., 2000, 73, p. 284-286.
3. Conn, P. M., Crowley, W. F. Gonadotropin-releasing hormone and its analogues. N. Engl. J. Med., 1991, 324, p. 93-103.
4. De Placido, G., Mollo, A., Alviggi, C., et al. Rescue of IVF cycles by HMG in pituitary down-regulated normogonadotrophic young women characterized by a poor initial response to recombinant FSH. Hum. Reprod., 2001, 16, p. 1875-1879.
5. Esposito, M. A., Barhnart, K. T., Coutifaris, C., et al. Role of periovulatory luteinizing hormone concentrations during assisted reproductive technology cycles stimulated exclusively with recombinant follicle-stimulating hormone. Fertil. Steril., 2001, 75, p. 519-524.
6. Filicori, M., Cognigni, G.E., Taraborrelli, S., et al. Luteinizing hormone activity in menotropins optimizes folliculogenesis and treatment in controlled ovarian stimulation. J. Clin. Endocrinol. Metab., 2001, 86, p. 337-343.
7. Fleming, R., Chung, C. C., Yates, R. W. S., et al. Purified urinary follicle stimulating hormone induces different hormone profiles compared to menotrophins, dependent upon the route of administration and endogenous luteinizing hormone activity. Hum. Reprod., 1986, 11, p. 1854-1858.
8. Fleming, R., Rehka, P., Deshpande, N., et al. Suppression of LH during ovarian stimulation: effects differ in cycles stimulated with purified urinary FSH and recombinant FSH. Hum. Reprod., 2000, 15, p. 1440-1445.
9. Hillier, S. G. Controlled ovarian stimulation in women. J. Reprod. Fertil., 2000, 120, p. 201-210.
10. Homburg, R., Arman, N. A., Esher, A., et al. Influence of serum luteinizing hormone concentration on ovulation, conception and early pregnancy loss in polycystic ovary syndrome. Br. J. Med., 1988, 297, p. 1024-1026.
11. Humaidan, P., Bungum, L., Bungum, M., et al. Ovarian response and pregnancy outcome related to mid-follicular LH levels in women undergoing assisted reproduction with GnRH agonist down-regulation and recombinant FSH stimulation. Hum. Reprod., 2002, 17, p. 2016-2021.
12. Chappel, S. C., Howles, C. Re-evaluation of the roles of luteinizing hormone in the ovulatory process. Hum. Reprod., 1991, 6, p. 1206-1212.
13. Jakimiuk, A. J., Weitsman, S. R., Navab, A., et al. Luteinizing hormone receptor, steroidogenesis acute regulatory protein, an steroidogenic enzyme messenger ribonucleic acids are overexpressed in thecal and granulosa cells from polycystic ovaries. J. Clin. Endocrinol., 2001, 86, p. 1318-1323.
14. Lam, P. M., Cheung, L. P., Choy, C. M. Y., et al. Effects of intensity of down regulation on outcome of in vitro fertilization and embryo transfer. Gynaecol. Endocrinol., 2002, 16, p. 143-150.
15. Peñarrubia, J., Fábregues, F., Creus, M., et al. LH serum levels during ovarian stimulation as predictors of ovarian response and assisted reproduction outcome in down-regulated women stimulated with recombinant FSH. Hum. Reprod., 2003, 18, p. 2289-2697.
16. Regan, L., Owen, E. J., Jacobs, H. S., et al. Hypersecretion of luteinizing hormone, infertility and miscarriage. Lancet, 1990, 336, p. 1141-1144.
17. Shoham, Z. The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation. Fertil. Steril., 2002, 77, p. 1170-1177.
18. Tesarik, J., Mandoza, C. Effects of exogenous LH administration during ovarian stimulation of pituitary down-regulated young oocyte donors on oocyte yield and developmental competence. Hum. Reprod., 2002, 17, p. 3129-3137.
19. Westergaard, L. G., Erb, K., Laursen, S. D., et al. The effect of human menopausal gonadothrophin and highly purified urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down regulated normogonadotrophic women. Hum. Reprod., 1996, 11, p. 1209-1213.
20. Westergaard, L. G., Laursen, S. B., Yding Andersen, C., et al. Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in IVF treated normogonadotrophic women. Hum. Reprod., 2000, 15, p. 1003-108.
21. Westergaard, L. G., Erb, K., Laursen, S. B., et al. Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm-injection: a prospective randomized study. Fertil. Steril., 2001, 76, p. 543-549.
22. Yim, S. F., Lok, L. H., Cheung, L. P., et al. Dose finding study for the use of long-acting gonadotrophin-releasing hormone analogues prior to ovarian stimulation. Hum. Reprod., 2001, 16, p. 492-494.